Delivery Order SPE2DB20D3103-SPE2DB25FM6L1
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DB22D1017|SPE2DB25FF2LL was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,509.41 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a cardiovascular medication, with a period of performance through January 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,805.52, is a delivery order contract for the provision of XARELTO 20 MG TABLET 90S, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of October 16, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,657.74 firm fixed-price contract covers the delivery of XARELTO 20 MG TABLET 90S, a cardiovascular medication. The contract award has an ultimate completion date of October 25, 2024 and was issued on October 24, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3303 and SPE2DB23FZ5Y5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,139.58 firm fixed-price delivery order is for the procurement of XARELTO 20 MG TABLET 90S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,921.46 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a cardiovascular medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award, valued at $43,738.13, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,137.63 firm fixed-price delivery order is for the supply of XARELTO 20 MG tablets, a cardiovascular medication, with a completion date of February 9, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,156.71 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FN01F, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,482.46 Firm Fixed Price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,155.45 firm fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a cardiovascular medication, with a performance period through November 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...